Cart
sales@molnova.com
PACAP 1-38
CAS No. 137061-48-4
PACAP 1-38( PACAP (1-38) human ovine rat | Pituitary Adenylate Cyclase Activating Polypeptide 38 )
Catalog No. M21596 CAS No. 137061-48-4
PACAP 1-38 is a neuropeptide with 38 amino acid residues.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 332 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 804 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePACAP 1-38
-
NoteResearch use only, not for human use.
-
Brief DescriptionPACAP 1-38 is a neuropeptide with 38 amino acid residues.
-
DescriptionPACAP 1-38 is a neuropeptide with 38 amino acid residues.
-
In Vitro——
-
In Vivo——
-
SynonymsPACAP (1-38) human ovine rat | Pituitary Adenylate Cyclase Activating Polypeptide 38
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number137061-48-4
-
Formula Weight4534.26
-
Molecular FormulaC203H331N63O53S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (22.05 mM)
-
SMILESNA
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Akira Arimura Min Li Vecihi Batuman.Potential Protective Action of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP38) on in Vitro and in Vivo Models of Myeloma Kidney Injury .2006 Jan 15;107(2):661-8.?
molnova catalog
related products
-
Stressin I
Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.
-
Thymopoietin II (33-...
Thymopoietin II (33-36)
-
Angiotensin I
Des-Leu10-angiotensin I is a nonapeptide that inhibits rabbit lung angiotensin-converting enzyme peptidyl-dipeptide hydrolase with a Ki value of 31 μM, which is generated from angiotensin I by the action of carboxypeptidase-like activities residing in the human platelet and mast cell.
